Ji Eun Lee

Ji Eun Lee

Auto-generated profile, based on publicly available information

Ji Eun Lee

Department of Radiology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Radiology
Verified
Journal Article
Closed access
JMJi Hye Min
Ji Hye Min
MLMin Woo Lee
Min Woo Lee
HPHee Sun Park
Hee Sun Park
DLDong Ho Lee
Dong Ho Lee
HPHyun Jeong Park
Hyun Jeong Park
JAJoonghyun Ahn
Joonghyun Ahn
Gadoxetic acid–enhanced MRI had high interobserver variability and low diagnostic performance in the detection of microvascular invasion of hepatocellular carcinoma; therefore, caution is required ... Background Accurate identification of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) before treatment is critical for selecting a proper treatment strategy. Purpose To evaluate the ...

1 October 2019 in Radiology
Verified
Journal Article
Closed access
JLJi Eun Lee
Ji Eun Lee
SCSeo-Youn Choi
Seo-Youn Choi
JMJi Hye Min
Ji Hye Min
BYBoem Ha Yi
Boem Ha Yi
MLMin Hee Lee
Min Hee Lee
JKJung Hoon Kim
Jung Hoon Kim
Revised high-risk stigmata and worrisome features of the 2017 international consensus guidelines are useful in identifying malignant intraductal papillary mucinous neoplasm (IPMN). Diagnostic perfo... Background Several changes have been made to the revised 2017 international consensus guidelines for management of pancreatic intraductal papillary mucinous neoplasms (IPMNs). However, the diagnost...

1 August 2023 in Radiology
Verified
Journal Article
Closed access
SLSunyoung Lee
Sunyoung Lee
JLJi Eun Lee
Ji Eun Lee
JHJeong Ah Hwang
Jeong Ah Hwang
HSHye Jung Shin
Hye Jung Shin
Background Ovarian-Adnexal Reporting and Data System (O-RADS) US provides a standardized method with which to stratify lesions into risk of malignancy categories, which is crucial for proper management. Purpose To perform a systematic review and meta-analysis to estimate malignancy rates for each O-RADS US score and evaluate the diagnostic performance of combined O-RADS US scores 4 and 5 in the diagnosis of malignancy. Materials and Methods A systematic literature search from the inception of the MEDLINE, EMBASE, and Web of Science databases through January 27, 2023, was performed for articles that reported using the O-RADS US stratification system and included malignancy rates per each O-RADS score. Bivariate random-effects models were used to determine the pooled malignancy rates for each O-RADS US score and to obtain summary estimates of the diagnostic performance of combined O-RADS US scores 4 and 5 in the diagnosis of malignant lesions. Results The final analysis included 18 studies consisting of 11 605 patients and 11 818 ovarian-adnexal lesions, with 2996 malignant (25.4%) and 8822 benign (74.6%) lesions. No malignant lesions were reported in O-RADS 1 category. The pooled percentages of malignancy were 0.6% (95% CI: 0.3, 1.0) for O-RADS 2, 3.9% (95% CI: 2.5, 5.4) for O-RADS 3, 43.5% (95% CI: 33.8, 53.2) for O-RADS 4, and 87.3% (95% CI: 83.0, 91.7) for O-RADS 5. The pooled sensitivity and specificity of combined O-RADS scores 4 and 5 in the diagnosis of malignant lesions were 95.6% (95% CI: 94.0, 97.2) and 76.6% (95% CI: 70.4, 82.7), respectively. Conclusion Each O-RADS US score provided the intended probability of malignant lesions as outlined by the O-RADS risk stratification system. When O-RADS US scores 4 and 5 were combined as a predictor for malignancy, O-RADS US showed a high sensitivity and moderate specificity. Clinical trial registration no. CRD42022352166 © RSNA, 2023 Supplemental material is available for this article.

30 April 2024 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
HRHyo Seon Ryu
Hyo Seon Ryu
HKHyun Jung Kim
Hyun Jung Kim
WJWoong Bae Ji
Woong Bae Ji
BKByung Chang Kim
Byung Chang Kim
JKJi Hun Kim
Ji Hun Kim
KCKorean Colon Cancer Multidisciplinary Committee
Korean Colon Cancer Multidisciplinary Committee
Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.

1 January 2022 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JHJeong Ah Hwang
Jeong Ah Hwang
JMJi Hye Min
Ji Hye Min
SKSeong Hyun Kim
Seong Hyun Kim
SCSeo-Youn Choi
Seo-Youn Choi
JLJi Eun Lee
Ji Eun Lee
JMJi Yoon Moon
Ji Yoon Moon
Hwang JA, et al. Korean J Radiol. 2022 Jan;23:e7. https://doi.org/10.3348/kjr.2021.0407

3 August 2018 in Journal of Medical Imaging and Radiation Oncology
Verified
Journal Article
Closed access
PDF file
JLJi Eun Lee
Ji Eun Lee
SCSeo‐Youn Choi
Seo‐Youn Choi
HLHae Kyung Lee
Hae Kyung Lee
BYBoem Ha Yi
Boem Ha Yi
MLMin Hee Lee
Min Hee Lee
WJWoo Kyoung Jeong
Woo Kyoung Jeong